Recombinant antibody expression platform

Home > services > Recombinant antibody expression platform

NBbiolab has launched its 293 and CHO platform, which offers higher yield performance within

Two weeks. This cost-effective production system enables small to large-scale antibody

production with a high level of consistency, making it an excellent complement for

target discovery, pre-evaluation pipelines, and overall providing added value to users.

Large-Scale Recombinant Antibody Production Services

NBbiolab provides a comprehensive large-scale recombinant antibody expression platform, integrating our proprietary gene synthesis technology with mammalian cell-based expression systems.

Simply provide your antibody sequence, and our expert team will manage the entire workflow, including:

· Project design & feasibility assessment

· Gene synthesis & vector construction

· Small-scale expression & purification

· Process optimization & scale-up production

We offer fully customized solutions, delivering recombinant antibodies from microgram to gram scale, meeting the demands of high-throughput research and large-scale production for both academic and industrial applications.

Service Process

微信截图_20250314104447.png

Service Advantages

微信截图_20250318145357.png

Services

Contact us

: Tel: +86 4008677715
+86 135 5108 6942

: Address: SME Incubation Park, 319 Qingpi Avenue, Chengdu, China.

: Email: service@nb-biolab.com

Membrane Protein Antibody

TCR-mimic VHH Antibody

VHH-based CAR Molecule

Small Molecule Antibody

Anti-Small Molecule Immune Complex Antibody

Camelid Antibody

Shark Antibody

Rabbit Monoclonal Antibody

Sheep Monoclonal Antibody

Protein expression platform